欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/2051/001
药品名称
Linagliptin STADA
活性成分
linagliptin 5.0 mg
剂型
Film-coated tablet
上市许可持有人
Stada Arzneimittel AG, Germany
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Portugal (PT)
Italy (IT)
Finland (FI)
Hungary (HU)
Czechia (CZ)
Linagliptin STADA
Denmark (DK)
Slovakia (SK)
Linagliptin STADA 5 mg filmom obalené tablety
Belgium (BE)
Linagliptin EG 5 mg filmomhulde tabletten
Slovenia (SI)
Luxembourg (LU)
Iceland (IS)
Linagliptin STADA
Ireland (IE)
Austria (AT)
Spain (ES)
许可日期
2021/04/21
最近更新日期
2024/10/24
药物ATC编码
A10BH05 linagliptin
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Multiple (Copy) Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
SE_H_2051_001_Final PL
Date of last change:2024/09/06
Final SPC
|
SE_H_2051_001_Final SPC
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase